Trastuzumab (anti-HER2), CAS [[180288-69-1]]

Produktübersicht

• Artikelname: Trastuzumab (anti-HER2), CAS [[180288-69-1]]
• Artikelnummer: MCE-HY-P9907A
• Hersteller Artikelnummer: HY-P9907A
• Alternativnummer: MCE-HY-P9907A-25MG,MCE-HY-P9907A-100MG,MCE-HY-P9907A-50MG,MCE-HY-P9907A-1MG,MCE-HY-P9907A-5MG,MCE-HY-P9907A-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: Anti-Human HER2, Humanized Antibody (anti-HER2)

Produktbeschreibung

Trastuzumab (anti-HER2) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (anti-HER2) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.

Produkteigenschaften

• Molekulargewicht: (145.42 kDa)
• Reinheit: 99.838
• CAS Nummer: [180288-69-1]
• Target-Kategorie: ADC Antibody,EGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies